LT - N,6-BIS(ARYL OR HETEROARYL)-1,3,5-TRIAZINE-2,4-DIAMINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER
EN - N,6-BIS(ARYL OR HETEROARYL)-1,3,5-TRIAZINE-2,4-DIAMINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
| (51) |
INT.CL. |
C07D 401/14 |
|
|
|
C07D 401/04 |
|
|
|
C07D 401/12 |
|
|
|
C07D 403/12 |
|
|
|
C07D 403/04 |
|
|
|
C07D 413/12 |
|
|
|
C07D 417/12 |
|
|
|
C07D 417/14 |
|
|
|
C07D 251/18 |
|
|
|
A61K 31/53 |
|
|
|
A61P 35/00 |
|
European patent
| (11) |
Number of the document |
3019490 |
| (13) |
Kind of document |
T |
| (96) |
European patent application number |
14745309.6 |
|
Date of filing the European patent application |
2014-07-10 |
| (97) |
Date of publication of the European application |
2016-05-18 |
| (45) |
Date of publication and mention of the grant of the patent |
2020-06-03
|
| (46) |
Date of publication of the claims translation |
|
PCT application
| (86) |
Number |
PCT/US2014/046204 |
|
Date |
2014-07-10 |
PCT application publication
| (87) |
Number |
WO 2015/006592 |
|
Date |
2015-01-15 |
Priority applications
| (30) |
Number |
Date |
Country code |
|
201361845352 P |
2013-07-11
|
US |
Inventors
| (72) |
TRAVINS, Jeremy, US
UTLEY, Luke, US
|
Grantee
| (73) |
Agios Pharmaceuticals, Inc.,
88 Sidney Street, Cambridge, MA 02139,
US
|
Title
| (54) |
N,6-BIS(ARYL OR HETEROARYL)-1,3,5-TRIAZINE-2,4-DIAMINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER |
| |
N,6-BIS(ARYL OR HETEROARYL)-1,3,5-TRIAZINE-2,4-DIAMINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER |
